undamentalytics Newsletter

Nephros Inc revenue

Nephros Inc's revenue was $18.8m in fiscal 2025, up 32.7% on the year before. Since fiscal 2010 ($2.9m) it has grown at a compound 13.2% a year. Over the last twelve months it was $20.7m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nephros Inc: revenue history, annual
Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue322222246109101014141921
Growth on the year before—−24.6%−18.4%−3.7%+0.5%+11.2%+19.3%+64.2%+49.3%+81.7%−17.2%+19.3%−2.4%+42.7%−0.5%+32.7%—
Gross profit1111111236565891213
Gross margin38.2%39.2%59.2%48.4%68.6%54.5%55.8%60.2%56.3%58.9%57.4%55.1%47.4%59.0%61.6%61.9%61.3%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Products $18.2M ▲ 29.9%
Royalty and Other Revenues $555,000 ▲ 337.0%
Services $520,000 ▲ 566.7%
Other Revenue $24,000 ▼ 44.2%

These categories overlap or exclude eliminations, so shares aren't shown.

From Nephros Inc's 10-K filed March 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Nephros Inc $20.7m 24.2% 19.3%
Jin Medical International Ltd. $20.7m -12.0% —
Vivos Therapeutics, Inc. $20.9m 45.2% 10.6%
Sonoma Pharmaceuticals, Inc. $21.9m 47.0% 19.9%
Baird Medical Investment Holdings Ltd $22.5m -39.2% —
Sensus Healthcare, Inc. $17.5m -53.4% -16.5%

Compare with peers

Head to head: NEPH vs ZJYLNEPH vs VVOSNEPH vs SNOABDMD vs NEPH

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Nephros Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nephros Inc.